For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Verapamil (Calcium channel blocker (non-dihydropyridine), class IV antiarrhythmic) – indications: Regular narrow-complex tachycardia, atrial fibrillation/flutter with rapid ventricular rate – adults. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Regular narrow-complex tachycardia, atrial fibrillation/flutter with rapid ventricular rate – adults
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.